Age-related activation of MKK/p38/NF-κB signaling pathway in lung: from mouse to human

Xiaoxia Ren1, Huadong Du2, Yan Li1

  • 1Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, PR China; Beijing Institute of Respiratory Medicine, Beijing 100020, PR China.

Insights

Aging alters lung inflammation responses. Aged lungs show sustained p38 pathway activation and delayed responses to lipopolysaccharide (LPS), increasing susceptibility to inflammatory injury.

Area of Science:

  • Immunology
  • Aging Research
  • Respiratory Medicine

Background:

  • Pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 increase with age in mouse lungs.
  • Aging is associated with elevated p38 phosphorylation in the lungs.

Purpose of the Study:

  • To investigate how aging affects p38 signaling pathway activation and inflammatory responses to LPS in mouse and human lungs.
  • To determine if sustained baseline activation and delayed LPS response in aged lungs contribute to inflammatory injury susceptibility.

Main Methods:

  • Mice (young and aged) were intranasally exposed to LPS.
  • Human lung tissue and cells (from different age groups) were exposed to LPS ex vivo.
  • Activation of p38, MKK, and NF-κB signaling pathways and pro-inflammatory cytokine production were measured.

Main Results:

  • Aged mice exhibited delayed and sustained p38 activation post-LPS compared to young mice.
  • Aged human lungs showed sustained baseline p38, MKK, and NF-κB activation and delayed LPS-induced inflammatory cytokine production.
  • LPS induced rapid p38 pathway activation in young human lung cells but not in older cells, with delayed responses in older cells.

Conclusions:

  • Sustained baseline p38 signaling and a delayed early-phase response to LPS in aged lungs are implicated in heightened susceptibility to inflammatory injury.
  • Aging significantly alters the innate immune response in the lungs, particularly the p38 signaling pathway's kinetics.